Abstract

    Open Access Review Article Article ID: JGRO-4-151

    Bacterial Vaginosis: Risk of Adverse Pregnancy Outcome

    Arif Faruqui*

    The reproductive health of a woman is vital not only for her general health, but also for that of her

    partner and child. Bacterial infections can affect pregnant women from implantation of the fertilized

    ovum through the time of delivery and peripartum period. They may also affect the fetus and newborn.

    Symptomatic pregnant women with confi rmed bacterial vaginosis should be treated. Treatment of

    pregnant women with asymptomatic bacterial vaginosis is controversial. Guidelines from the Centers for

    Disease Control and Prevention (CDC) recommend treating asymptomatic high-risk pregnant women with

    bacterial vaginosis. Antibiotic treatment can eradicate bacterial vaginosis in pregnancy but overall risk of

    preterm birth (PTB) is not signifi cantly reduced. Present antibiotic therapy (metronidazole and

    clindamycin), both oral and vaginal, do not reduce the risk of PTB. Probiotics have capability to increase

    vaginal lactobacilli, restore the vaginal microbiota to normal and hence helps to cure bacterial vaginosis.

    Therefore, Probiotics should be considered as part of the prevention and as an adjunct to antimicrobial

    treatment approach for BV.

    Keywords:

    Published on: Jun 20, 2018 Pages: 15-17

    Full Text PDF Full Text HTML DOI: 10.17352/jgro.000051
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Case Reports

    Pinterest on JGRO